Anti HBsAg monoclonal antibody (Yeda Research and Development)

N/A

Report date: 2022/02/21 14:19:47

Base Information

Drug NameAnti HBsAg monoclonal antibody (Yeda Research and Development)
Drug Alias Nameanti HBsAg monoclonal antibody (HBV infection)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHepatitis B virus inhibitors
TargetsHepatitis B virus
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYeda Research And Development Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYeda Research And Development Company
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A